Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |